Weight-based pembrolizumab dosing demonstrated comparable effectiveness and safety to fixed dosing in patients with advanced non-small cell lung cancer (NSCLC). In a real-world cohort of 414 patients, ...

Please provide your email address to receive an email when new articles are posted on . In this video, Ursula A. Matulonis, MD, shares insight on the phase 3 KEYNOTE-B96 trial of pembrolizumab ...

Dosage for Keytruda may vary based on the condition it’s being used to treat. The typical starting dose is 200 mg every 3 weeks or 400 mg every 6 weeks. Your doctor may adjust your dosage. The active ...

Overview: Keytruda Qlex is a medicine that is used to treat many types of cancer. This medicine is given to you as an injection under your skin by a health care provider. This medicine can cause side ...